Biib

[jiesen]

Biogen recently had a drug approved to treat Alzheimer's Disease. Anyone else thinking of putting $$ into BIIB and/or other stocks with promising AD treatments? The price tag for Aduhelm (the newly-approved drug) is >$50k/year... this sector is going to be absolutely HUUUUUUUUUUUGGGGGEEEE in the coming months, imo.

[jiesen]

Biogen recently had a drug approved to treat Alzheimer's Disease. Anyone else thinking of putting $$ into BIIB and/or other stocks with promising AD treatments? The price tag for Aduhelm (the newly-approved drug) is >$50k/year... this sector is going to be absolutely HUUUUUUUUUUUGGGGGEEEE in the coming months, imo.

I took a bite into ESALY (Eisai) a few days ago, at about $99/shr. They have another promising Alzheimer's drug, as well as a collaboration with BIIB, so either way, a winner if one of these pans out.